Stabilization of Virus-like Particles with Poly(2-oxazoline)s.

17:02 EDT 1st September 2014 | BioPortfolio

Summary of "Stabilization of Virus-like Particles with Poly(2-oxazoline)s."

No Summary Available

Affiliation

Department of Chemistry and The Skaggs Institute for Chemical Biology, The Scripps Research Institute, 10550 North Torrey Pines Road, La Jolla, CA 92037 (USA), Fax: (+1) 858-784-8850 http://www.scripps.edu/chem/finn/

Journal Details

This article was published in the following journal.

Name: Angewandte Chemie (International ed. in English)
ISSN: 1521-3773
Pages: 2601-5

Links

PubMed Articles [7570 Associated PubMed Articles listed on BioPortfolio]

Poly(2-substituted-2-oxazoline) surfaces for dermal fibroblasts adhesion and detachment.

The thermoresponsive surfaces of brush structure (linear polymer chains tethered on the surface) based on poly(2-isopropyl-2-oxazoline)s and copolymers of 2-ethyl-2-oxazoline and 2-nonyl-2-oxazoline w...

Structure of poly(N-isopropylacrylamide) brushes and steric stability of their grafted cellulose nanocrystal dispersions.

Thermo-responsive poly(N-isopropylacrylamide) (poly(NIPAAm)) brushes were grafted from the surface of cellulose nanocrystals (CNC) via living radical polymerization (LRP) using different initiator and...

Effect of a Ru(ii) polypyridyl complex Ru(bpy)2(mdpz)(2+) on the stabilization of the RNA triplex poly(U)·poly(A)*poly(U).

There is renewed interest in investigating triplex nucleic acids because triplexes may be implicated in a range of cellular functions. However, the stabilization of triplex nucleic acids is essential ...

Virus particles in phloem exudate from Cucumis sativus L. after infection by Cucumis Virus 2 A.

Sieve tube sap obtained from cucumber plants infected by Cucumis Virus 2 A induced the typical mosaic disease when it was inoculated into healthy plants of the same species. The infectious factor coul...

Physical adsorption of anisotropic titania nanoparticles onto poly(2-vinylpyridine) latex and characterisation of the resulting nanocomposite particles.

Four poly(2-vinylpyridine) latexes with intensity-average mean diameters ranging between 246 and 955nm were prepared by aqueous emulsion polymerisation. These latexes were characterised by transmissio...

Clinical Trials [1307 Associated Clinical Trials listed on BioPortfolio]

Phase I Oncovir Poly IC:LC and NY-ESO-1/gp100/MART

The purpose of this study is to determine what side effects CP 870,893 may cause when given with an immune stimulant called Oncovir poly IC:LC along with a melanoma vaccine. The CP 870,893...

Poly-ICLC in Treating Patients With Recurrent or Progressive Anaplastic Glioma

RATIONALE: Biological therapies such as poly-ICLC use different ways to stimulate the immune system and stop tumor cells from growing. PURPOSE: This phase II trial is studying how poly-IC...

DCVax Plus Poly ICLC in Healthy Volunteers

DCVax-001 is a recombinant protein vaccine designed to prevent and potentially treat human immunodeficiency virus (HIV) infection. The vaccine is composed of a fusion protein containing a ...

Effects of Vaccinations With HLA-A2-Restricted Glioma Antigen-Peptides in Combination With Poly-ICLC for Adults With High-Risk WHO Grade II Astrocytomas and Oligo-Astrocytomas

This is a pilot vaccine study in adults with either WHO grade II astrocytoma or oligoastrocytoma. The purpose of this study is test the safety and efficacy of an experimental tumor vaccine...

HLA-A2-Restricted Glioma Antigen-Peptides Vaccinations With Poly-ICLC for Recurrent WHO Grade II Gliomas

This is a pilot vaccine study in adults with recurrent WHO Grade II gliomas. The purpose of this study is to test the safety and efficacy of an experimental tumor vaccine made from peptide...

Medical and Biotech [MESH] Definitions

A poly(A) binding protein that has a variety of functions such as mRNA stabilization and protection of RNA from nuclease activity. Although poly(A) binding protein I is considered a major cytoplasmic RNA-binding protein it is also found in the CELL NUCLEUS and may be involved in transport of mRNP particles.

A poly(A) binding protein that is involved in promoting the extension of the poly A tails of MRNA. The protein requires a minimum of ten ADENOSINE nucleotides in order for binding to mRNA. Once bound it works in conjunction with CLEAVAGE AND POLYADENYLATION SPECIFICITY FACTOR to stimulate the rate of poly A synthesis by POLY A POLYMERASE. Once poly-A tails reach around 250 nucleotides in length poly(A) binding protein II no longer stimulates POLYADENYLATION. Mutations within a GCG repeat region in the gene for poly(A) binding protein II have been shown to cause the disease MUSCULAR DYSTROPHY, OCULOPHARYNGEAL.

Proteins encoded by a VIRAL GENOME that are produced in the organisms they infect, but not packaged into the VIRUS PARTICLES. Some of these proteins may play roles within the infected cell during VIRUS REPLICATION or act in regulation of virus replication or VIRUS ASSEMBLY.

The interactions of particles responsible for their scattering and transformations (decays and reactions). Because of interactions, an isolated particle may decay into other particles. Two particles passing near each other may transform, perhaps into the same particles but with changed momenta (elastic scattering) or into other particles (inelastic scattering). Interactions fall into three groups: strong, electromagnetic, and weak. (From McGraw-Hill Encyclopedia of Science & Technology, 7th ed)

The binding of virus particles to receptors on the host cell surface. For enveloped viruses, the virion ligand is usually a surface glycoprotein as is the cellular receptor. For non-enveloped viruses, the virus CAPSID serves as the ligand.

Search BioPortfolio:
Advertisement
Advertisement

Searches Linking to this Article